Changping Shan

机构：Affiliated Hospital of Jining Medical University, Jining Medical University

发表论文 19 篇 · 总被引 241 次 · h-index 6

代表论文

• MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7 (2018 · Biochimie · 被引 101)
• Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial (2023 · Acta Pharmaceutica Sinica B · 被引 60)
• CircRNA Hsa_circ_0001017 Inhibited Gastric Cancer Progression via Acting as a Sponge of miR-197 (2020 · Digestive Diseases and Sciences · 被引 26)
• Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study (2022 · Cancer Medicine · 被引 18)
• Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial (2025 · Nature Communications · 被引 11)
• Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial (2025 · 癌症：英文版 · 被引 9)